140 related articles for article (PubMed ID: 8665063)
1. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome.
Chin K; Ohi M; Kita H; Noguchi T; Otsuka N; Tsuboi T; Mishima M; Kuno K
Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1972-6. PubMed ID: 8665063
[TBL] [Abstract][Full Text] [Related]
2. Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure.
Reinhart WH; Oswald J; Walter R; Kuhn M
Clin Hemorheol Microcirc; 2002; 27(3-4):201-7. PubMed ID: 12454377
[TBL] [Abstract][Full Text] [Related]
3. New insights into the therapy and pathophysiology of patients with obstructive sleep apnoea syndrome.
Chin K; Ohi M
Respirology; 1998 Jun; 3(2):139-43. PubMed ID: 9692524
[TBL] [Abstract][Full Text] [Related]
4. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome.
Nobili L; Schiavi G; Bozano E; De Carli F; Ferrillo F; Nobili F
Clin Hemorheol Microcirc; 2000; 22(1):21-7. PubMed ID: 10711818
[TBL] [Abstract][Full Text] [Related]
5. [Nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome].
Huang XZ
Zhonghua Jie He He Hu Xi Za Zhi; 1991 Aug; 14(4):225-7, 256. PubMed ID: 1802439
[TBL] [Abstract][Full Text] [Related]
6. [Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). I: Long-term acceptance of nasal CPAP].
Hollandt JH; Kuhl S; Siegert R
Laryngorhinootologie; 1997 Sep; 76(9):550-3. PubMed ID: 9417184
[TBL] [Abstract][Full Text] [Related]
7. Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome.
Chin K; Kita H; Noguchi T; Otsuka N; Tsuboi T; Nakamura T; Shimizu K; Mishima M; Ohi M
QJM; 1998 Sep; 91(9):627-33. PubMed ID: 10024917
[TBL] [Abstract][Full Text] [Related]
8. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.
Kita H; Ohi M; Chin K; Noguchi T; Otsuka N; Tsuboi T; Itoh H; Nakao K; Kuno K
J Sleep Res; 1998 Sep; 7(3):199-207. PubMed ID: 9785275
[TBL] [Abstract][Full Text] [Related]
9. [Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). II: Side-effects of nCPAP therapy. Effect on long-term acceptance].
Kuhl S; Hollandt JH; Siegert R
Laryngorhinootologie; 1997 Oct; 76(10):608-13. PubMed ID: 9445527
[TBL] [Abstract][Full Text] [Related]
10. [Predictive factors of minimally effective nCPAP ventilation in treatment of obstructive sleep apnea?].
Teschler H; Hoheisel G; Wagner B; Schumann H; Konietzko N
Med Klin (Munich); 1995 Jun; 90(6):330-7. PubMed ID: 7637664
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment.
Jennum P; Wildschiødtz G; Christensen NJ; Schwartz T
Am J Hypertens; 1989 Nov; 2(11 Pt 1):847-52. PubMed ID: 2686712
[TBL] [Abstract][Full Text] [Related]
12. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.
Carneiro G; Togeiro SM; Hayashi LF; Ribeiro-Filho FF; Ribeiro AB; Tufik S; Zanella MT
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of demand of positive airway pressure therapy for treating obstructive sleep apnea syndrome].
García Arroyo I; Terán Santos J; Cordero Guevara J; Rodríguez Pascual L
Arch Bronconeumol; 1999 May; 35(5):208-13. PubMed ID: 10378047
[TBL] [Abstract][Full Text] [Related]
14. [Effects of nCPAP therapy on the blood picture in patients with obstructive sleep apnea].
Sanner B; Konermann M; Doberauer C; Laschewski F; Kreuzer I
Pneumologie; 1995 Jul; 49(7):413-7. PubMed ID: 7675756
[TBL] [Abstract][Full Text] [Related]
15. [Results of 248 patients with sleep apnea syndrome treated by continuous positive pressure ventilation between 1990 and 1995. A study of compliance and outcome of the apnea-hypopnea index].
Lacassagne L; Didier A; Doussau S; Murris-Espin M; Birot P; Charlet JP; Thach KS; Tiberge M; Paoli JR; Pessey JJ; Léophonte P
Rev Mal Respir; 2000 Apr; 17(2):467-74. PubMed ID: 10859765
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 72 level decreases during sleep in patients with obstructive sleep apnea syndrome.
Noguchi T; Chin K; Ohi M; Kita H; Otsuka N; Tsuboi T; Satoh M; Nakai A; Kuno K; Nagata K
Am J Respir Crit Care Med; 1997 Apr; 155(4):1316-22. PubMed ID: 9105073
[TBL] [Abstract][Full Text] [Related]
17. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk.
Steiner S; Jax T; Evers S; Hennersdorf M; Schwalen A; Strauer BE
Cardiology; 2005; 104(2):92-6. PubMed ID: 16015032
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation in patients with obstructive sleep apnea syndrome and effects of nasal-continuous positive airway pressure.
Shimizu M; Kamio K; Haida M; Ono Y; Miyachi H; Yamamoto M; Shinohara Y; Ando Y
Tokai J Exp Clin Med; 2002 Dec; 27(4):107-12. PubMed ID: 12713015
[TBL] [Abstract][Full Text] [Related]
19. Evidence for lipid peroxidation in obstructive sleep apnea.
Lavie L; Vishnevsky A; Lavie P
Sleep; 2004 Feb; 27(1):123-8. PubMed ID: 14998248
[TBL] [Abstract][Full Text] [Related]
20. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.
Christou K; Kostikas K; Pastaka C; Tanou K; Antoniadou I; Gourgoulianis KI
Sleep Med; 2009 Jan; 10(1):87-94. PubMed ID: 18077211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
